KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesDividends payablesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abbott Laboratories (ABT) Short-term Investments (2016 - 2026)

Abbott Laboratories' Short-term Investments history spans 18 years, with the latest figure at $492.0 million for Q1 2026.

  • On a quarterly basis, Short-term Investments rose 57.69% to $492.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $492.0 million, a 57.69% increase, with the full-year FY2025 number at $417.0 million, up 18.8% from a year prior.
  • Short-term Investments hit $492.0 million in Q1 2026 for Abbott Laboratories, up from $417.0 million in the prior quarter.
  • Over the last five years, Short-term Investments for ABT hit a ceiling of $492.0 million in Q1 2026 and a floor of $222.0 million in Q3 2025.
  • Historically, Short-term Investments has averaged $341.4 million across 5 years, with a median of $338.0 million in 2023.
  • Biggest five-year swings in Short-term Investments: tumbled 36.0% in 2022 and later skyrocketed 57.69% in 2026.
  • Tracing ABT's Short-term Investments over 5 years: stood at $288.0 million in 2022, then skyrocketed by 32.99% to $383.0 million in 2023, then decreased by 8.36% to $351.0 million in 2024, then rose by 18.8% to $417.0 million in 2025, then grew by 17.99% to $492.0 million in 2026.
  • Business Quant data shows Short-term Investments for ABT at $492.0 million in Q1 2026, $417.0 million in Q4 2025, and $222.0 million in Q3 2025.